OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Facebook

RSS

Youtube

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Blog

Deb Schrag and Lorenz Studer have been elected to the National Academy of Medicine

Collage Photo of Deb Schrag and Lorenz Studer

Oct 22, 2024, 14:00

Deb Schrag and Lorenz Studer have been elected to the National Academy of Medicine

Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center, have been elected to the National Academy of Medicine.

This year, NAM elected 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

The National Academy of Medicine (NAM), established as the Institute of Medicine in 1970 by the National Academy of Sciences, addresses vital issues in health, science, medicine, and policy. NAM collaborates with the National Academy of Sciences and the National Academy of Engineering to offer independent, objective analysis and recommendations on complex problems and public policy. The National Academies of Sciences, Engineering, and Medicine promote education, research, and public understanding of STEMM fields, while recognizing exceptional contributions. NAM members commit to volunteering in various activities to support these goals.

Dr. Deb Schrag is the Chair of the Department of Medicine at Memorial Sloan Kettering (MSK), where she leads nearly 500 faculty members in advancing cancer therapies and patient care. A medical oncologist specializing in gastrointestinal cancers, Dr. Schrag is internationally recognized for her research in health services, focusing on improving cancer outcomes and equity. Prior to MSK, she was Chief of Population Sciences at Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School.

Dr. Lorenz Studer is a leading stem cell biologist known for his groundbreaking work in developing therapies for cancer and degenerative diseases like Parkinson’s and ALS. As the head of The Lorenz Studer Lab at MSK, he and his team focus on using human pluripotent stem cells for disease modeling, drug discovery, and cell therapy. Dr. Studer has revolutionized approaches to cell fate, maturation, and aging, particularly in neurodegenerative disease research. He also pioneered a stem cell-based transplantation therapy for Parkinson’s disease and is the founding director of MSK’s Center for Stem Cell Biology.

Deb Schrag and Lorenz Studer have been elected to the National Academy of Medicine

On this occasion Memorial Sloan Kettering Cancer Center posted on X:

“Congratulations to Dr. Deb Schrag, Chair of the Memorial Sloan Kettering Cancer Center, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at MSK, who were elected to the NAM, one of the highest honors bestowed upon scientists worldwide.”

For more information visit oncodaily.com